Oligodendrocytes modulate the immune-inflammatory response in EAE via TNFR2 signaling

Brain, Behavior, and Immunity - Tập 84 - Trang 132-146 - 2020
Pernille M. Madsen1,2, Haritha L. Desu1,3, Juan Pablo de Rivero Vaccari1, Yoleinny Florimon1, Ditte G. Ellman2, Robert W. Keane1,3,4, Bettina H. Clausen2,5, Kate L. Lambertsen2,6,5, Roberta Brambilla1,2,3,5
1The Miami Project to Cure Paralysis, Dept. Neurological Surgery, University of Miami Miller School of Medicine, FL 33136, USA
2Dept. Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
3The Neuroscience Program, University of Miami Miller School of Medicine, Miami, FL 33136, USA
4Dept. Physiology and Biophysics, University of Miami Miller School of Medicine, FL 33136, USA
5BRIDGE – Brain Research Inter Disciplinary Guided Excellence, Department of Clinical Research, University of Southern Denmark, Odense, Denmark
6Department of Neurology, Odense University Hospital, Odense, Denmark

Tài liệu tham khảo

Aboul-Enein, 2003, Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases, J. Neuropathol. Exp. Neurol., 62, 25, 10.1093/jnen/62.1.25 Argaw, 2006, IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program, J. Immunol., 177, 5574, 10.4049/jimmunol.177.8.5574 Arnett, 2001, TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination, Nat. Neurosci., 4, 1116, 10.1038/nn738 Balabanov, 2007, Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis, J. Neurosci., 27, 2013, 10.1523/JNEUROSCI.4689-06.2007 Black, 1997, A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells, Nature, 385, 729, 10.1038/385729a0 Boven, 2000, Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions, Clin. Exp. Immunol., 122, 257, 10.1046/j.1365-2249.2000.01334.x Brambilla, 2019, The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis, Acta Neuropathol., 10.1007/s00401-019-01980-7 Brambilla, 2011, Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination, Brain, 134, 2736, 10.1093/brain/awr199 Constantinescu, 2011, Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS), Br. J. Pharmacol., 164, 1079, 10.1111/j.1476-5381.2011.01302.x Corcoran, 2016, HIF1alpha and metabolic reprogramming in inflammation, J. Clin. Invest., 126, 3699, 10.1172/JCI84431 Dostert, 2019, The TNF family of ligands and receptors: communication modules in the immune system and beyond, Physiol. Rev., 99, 115, 10.1152/physrev.00045.2017 Du, 2009, MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis, Nat. Immunol., 10, 1252, 10.1038/ni.1798 Dumas, 2014, The inflammasome pyrin contributes to pertussis toxin-induced IL-1beta synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitis, PLoS Pathog., 10, 10.1371/journal.ppat.1004150 Falcao, 2018, Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis, Nat. Med., 24, 1837, 10.1038/s41591-018-0236-y Farez, 2009, Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE, Nat. Immunol., 10, 958, 10.1038/ni.1775 Freeman, 2013, Evolving concepts of gliogenesis: a look way back and ahead to the next 25 years, Neuron, 80, 613, 10.1016/j.neuron.2013.10.034 Gao, 2017, Opposing Functions of Microglial and Macrophagic TNFR2 in the Pathogenesis of Experimental Autoimmune Encephalomyelitis, Cell Rep., 18, 198, 10.1016/j.celrep.2016.11.083 Gerhardt, 2015, Monocyte trafficking across the vessel wall, Cardiovasc. Res., 107, 321, 10.1093/cvr/cvv147 Grell, 1995, The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor, Cell, 83, 793, 10.1016/0092-8674(95)90192-2 Grell, 1998, The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor, Proc. Natl. Acad. Sci. U.S.A, 95, 570, 10.1073/pnas.95.2.570 Gris, 2010, NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses, J. Immunol., 185, 974, 10.4049/jimmunol.0904145 Hansen, 2013, Natural RNA circles function as efficient microRNA sponges, Nature, 495, 384, 10.1038/nature11993 Hofman, 1989, Tumor necrosis factor identified in multiple sclerosis brain, J. Exp. Med., 170, 607, 10.1084/jem.170.2.607 Holtmann, 2004, Differential TNF-signaling in chronic inflammatory disorders, Curr. Mol. Med., 4, 439, 10.2174/1566524043360636 Honardoost, 2014, miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis, Gene, 544, 128, 10.1016/j.gene.2014.04.069 Imtiyaz, 2010, Hypoxia-inducible factors as essential regulators of inflammation, Curr. Top. Microbiol. Immunol., 345, 105 Inoue, 2013, NLRP3 Inflammasome and MS/EAE, Autoimmune Dis., 2013 Jäkel, 2019, Altered human oligodendrocyte heterogeneity in multiple sclerosis, Nature, 10.1038/s41586-019-0903-2 Jang, 2016, 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome, Nat. Commun., 7, 13129, 10.1038/ncomms13129 Kang, 2013, Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells, Nat. Neurosci., 16, 1401, 10.1038/nn.3505 Karim, 2018, Increase in chemokine CXCL1 by ERbeta ligand treatment is a key mediator in promoting axon myelination, Proc. Natl. Acad. Sci. U.S.A, 115, 6291, 10.1073/pnas.1721732115 Kemanetzoglou, 2017, CNS Demyelination with TNF-alpha Blockers, Curr. Neurol. Neurosci. Rep., 17, 36, 10.1007/s11910-017-0742-1 Kriegler, 1988, A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF, Cell, 53, 45, 10.1016/0092-8674(88)90486-2 Levesque, 2016, Myeloid cell transmigration across the CNS vasculature triggers IL-1beta-driven neuroinflammation during autoimmune encephalomyelitis in mice, J. Exp. Med., 213, 929, 10.1084/jem.20151437 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 Lucchinetti, 2000, Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Ann. Neurol., 47, 707, 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q Madsen, 2015, Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia, J. Cereb. Blood Flow Metab. Madsen, 2016, Oligodendroglial TNFR2 mediates membrane TNF-dependent repair in experimental autoimmune encephalomyelitis by promoting oligodendrocyte differentiation and remyelination, J. Neurosci., 36, 5128, 10.1523/JNEUROSCI.0211-16.2016 Madsen, 2017, Prolonged stimulation of a brainstem raphe region attenuates experimental autoimmune encephalomyelitis, Neuroscience, 346, 395, 10.1016/j.neuroscience.2017.01.037 Miyagishi, 1997, Identification of cell types producing RANTES, MIP-1 alpha and MIP-1 beta in rat experimental autoimmune encephalomyelitis by in situ hybridization, J. Neuroimmunol., 77, 17, 10.1016/S0165-5728(97)00040-4 Moreno, 2014, Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE, J. Neurosci., 34, 8175, 10.1523/JNEUROSCI.1137-14.2014 Moss, 1997, Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha, Nature, 385, 733, 10.1038/385733a0 Moyon, 2015, Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support their migration, J. Neurosci., 35, 4, 10.1523/JNEUROSCI.0849-14.2015 Olson, 2004, Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs, J. Immunol., 173, 3916, 10.4049/jimmunol.173.6.3916 Omari, 2009, Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1, Am. J. Pathol., 174, 164, 10.2353/ajpath.2009.080350 Petkovic, 2016, Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation, Glia, 64, 2104, 10.1002/glia.23043 Probert, 2015, TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects, Neuroscience, 302, 2, 10.1016/j.neuroscience.2015.06.038 Radu, 2013, An in vivo assay to test blood vessel permeability, J Vis Exp, 10.3791/50062 Ransohoff, 2012, The anatomical and cellular basis of immune surveillance in the central nervous system, Nat. Rev. Immunol., 12, 623, 10.1038/nri3265 Ransohoff, 1993, Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis, FASEB J., 7, 592, 10.1096/fasebj.7.6.8472896 Scheld, 2019, Mitochondrial Impairment in Oligodendroglial Cells Induces Cytokine Expression and Signaling, J. Mol. Neurosci., 67, 265, 10.1007/s12031-018-1236-6 Schonrock, 2000, Interleukin-6 expression in human multiple sclerosis lesions, Neurosci. Lett., 294, 45, 10.1016/S0304-3940(00)01543-3 Selmaj, 1991, Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions, J. Clin. Invest., 87, 949, 10.1172/JCI115102 Semenza, 2012, Hypoxia-inducible factors in physiology and medicine, Cell, 148, 399, 10.1016/j.cell.2012.01.021 Sharief, 1991, Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis, N. Engl. J. Med., 325, 467, 10.1056/NEJM199108153250704 Simon, 2011, Progenitors in the adult cerebral cortex: cell cycle properties and regulation by physiological stimuli and injury, Glia, 59, 869, 10.1002/glia.21156 Suvannavejh, 2000, Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35–55)-induced experimental autoimmune encephalomyelitis, Cell. Immunol., 205, 24, 10.1006/cimm.2000.1706 Taoufik, 2011, Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-kappaB, Brain, 134, 2722, 10.1093/brain/awr203 Van Der Voorn, 1999, Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions, Am. J. Pathol., 154, 45, 10.1016/S0002-9440(10)65249-2 Voet, 2019, Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology, Trends Mol. Med., 25, 112, 10.1016/j.molmed.2018.11.005 Zeis, 2016, The immunomodulatory oligodendrocyte, Brain Res., 1641, 139, 10.1016/j.brainres.2015.09.021 Zhang, 2014, An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex, J. Neurosci., 34, 11929, 10.1523/JNEUROSCI.1860-14.2014